E-LIB Suche - Ergebnisse für: Schlag, R.

1

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TRE..:

Langerbeins, P. ; Robrecht, S. ; Nieper, P....
Hematological Oncology. 41 (2023) S2 - p. 56-58 , 2023

Link: https://doi.org/10.1002/..

2

P636: REAL WORLD OUTCOME WITH IBRUTINIB IN PATIENTS WITH CH..:

Welslau, M. ; Schlag, R. ; Heinrich, B....
HemaSphere. 6 (2022) - p. 534-535 , 2022

Link: https://doi.org/10.1097/..

3

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TRE..:

Langerbeins, P. ; Bahlo, J. ; Rhein, C....
Hematological Oncology. 37 (2019) S2 - p. 38-40 , 2019

Link: https://doi.org/10.1002/..

4

RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOT..:

Hoster, E. ; Unterhalt, M. ; Hänel, M....
Hematological Oncology. 35 (2017) S2 - p. 32-32 , 2017

Link: https://doi.org/10.1002/..

5

Challenging IWG2006 Response Criteria: Results of a Randomi..:

Fenaux, P. ; Santini, V. ; Aloe Spiriti, M....
Leukemia Research. 55 (2017) - p. S23 , 2017

Link: https://doi.org/10.1016/..

6

A084 Similar Benefit in Patients Aged q 75 Years Versus < 7..:

Kropff, M ; Richardson, PG ; Schlag, R...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S12 , 2009

Link: https://doi.org/10.1016/..

7

A232 Superior Survival with VMP Versus MP After Longer Foll..:

San Miguel, J ; Dimopoulos, MA ; Schlag, R...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S39-S40 , 2009

Link: https://doi.org/10.1016/..

8

A235 A Prolonged Therapy Improves Quality of Response, and ..:

Harousseau, JL ; Niesvizky, R ; Palumbo, A...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S40 , 2009

Link: https://doi.org/10.1016/..

9

A217 Erythropoiesis-Stimulating Agents: No Impact on Long-T..:

Richardson, PG ; Liu, K ; Deraedt, W...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S35-S36 , 2009

Link: https://doi.org/10.1016/..

10

A246 VMP Results in Fewer Bone Events and Greater ALP Incre..:

Delforge, M ; Kropff, M ; Spicka, I...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S43 , 2009

Link: https://doi.org/10.1016/..

11

A220 Bortezomib and Melphalan as Part of VMP Are Associated..:

Richardson, PG ; Schlag, R ; Khuageva, N...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S36-S37 , 2009

Link: https://doi.org/10.1016/..

12

A172 Peripheral Neuropathy with VMP Resolves in the Majorit..:

Mateos, MV ; Richardson, PG ; Schlag, R...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S30 , 2009

Link: https://doi.org/10.1016/..

13

A166 VMP in Renally Impaired Newly Diagnosed MM Patients: C..:

Dimopoulos, MA ; Richardson, PG ; Schlag, R...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S29 , 2009

Link: https://doi.org/10.1016/..

14

Lead Levels in the Household Environment of Children in 3 H..:

Sutton, P.M. ; Athanasoulis, M. ; Flessel, P....
Environmental Research. 68 (1995) 1 - p. 45-57 , 1995

Link: https://doi.org/10.1006/..

15

827 Radiotherapy-enhancing effect of ifosfamide in human NS..:

Hinkelbein, W. ; Ruhnau, T. ; Schlag, R..
European Journal of Cancer. 31 (1995) - p. S173 , 1995

Link: https://doi.org/10.1016/..